Provided by Tiger Fintech (Singapore) Pte. Ltd.

SINO BIOPHARM

3.320
+0.0100.30%
Volume:82.32M
Turnover:272.59M
Market Cap:62.32B
PE:24.59
High:3.370
Open:3.340
Low:3.280
Close:3.310
Loading ...

Sino Biopharmaceutical - Deal for RMB630.0 Million

THOMSON REUTERS
·
30 Oct 2024

Sino Biopharmaceutical - Acquisition of 29.99% Equity Interest in Target Company

THOMSON REUTERS
·
30 Oct 2024

Sino Biopharmaceutical - Unit Entered Equity Transfer Agreement With Hob Biotech HK

THOMSON REUTERS
·
30 Oct 2024

Sino Biopharmaceutical's Cancer Drug Gets Marketing Nod from NMPA After Phase III Trials

MT Newswires Live
·
21 Oct 2024

Stock Track | Sino Biopharm Shares Plunge After Major Licensing Deal

Stock Track
·
08 Oct 2024

Sino Biopharm Unit Obtains China License for YZY Bio's Cancer Drug

MT Newswires Live
·
08 Oct 2024

BRIEF-Sino Biopharmaceutical Announces Exclusive License And Cooperation Deal With YZY Biopharma

Reuters
·
08 Oct 2024

Sino Biopharmaceutical - Unit Will Pay Approximately RMB315 Mln as Upfront Payment

THOMSON REUTERS
·
08 Oct 2024

Sino Biopharmaceutical - Unit Obtained License for Development, Commercialization of M701 Developed by Yzy Biopharma in Mainland China

THOMSON REUTERS
·
08 Oct 2024

Sino Biopharmaceutical - Signing of an Exclusive License and Cooperation Agreement With Yzy Biopharma

THOMSON REUTERS
·
08 Oct 2024

Stock Track | Sino Biopharm Shares Soar on Subsidiary's Share Buyback

Stock Track
·
04 Oct 2024

Sino Biopharmaceutical Unit Buys 187 Milion Shares Under Award Scheme

MT Newswires Live
·
04 Oct 2024

After Leaping 27% Sino Biopharmaceutical Limited (HKG:1177) Shares Are Not Flying Under The Radar

Simply Wall St.
·
03 Oct 2024

Chinese Regulator Approves Sino Biopharmaceutical's Alzheimer Treatment Patch for Marketing

MT Newswires Live
·
25 Sep 2024

Sino Biopharmaceutical - Approval for Marketing of "Rivastigmine Transdermal Patch" by Nmpa

THOMSON REUTERS
·
25 Sep 2024

Sino Biopharmaceutical Limited's (HKG:1177) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Simply Wall St.
·
20 Sep 2024